Abstract
Much has been learned about the treatment of obsessive-compulsive disorders (OCD) in the last decade. Diagnostic criteria are now well-defined, adequate numbers of patients are currently available, and we now have an assessment instrument (the Yale-Brown Obsessive Compulsive Scale) that is sensitive to change and has demonstrated reliability and validity. We currently have medications that have been well-studied in adequately designed controlled trials that predictably help the majority of OCD patients. This paper will review the considerable data on the use of medications in patients with OCD. In addition, an approach to patients with resistant symptoms will be presented.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
